Skip to main content
. 2010 Jan 29;10:3. doi: 10.1186/1472-6904-10-3

Table 9.

Contents of the commercial samples

Samples Piperacillin/Tazobactam Meropenem

Group 1 Group 2 Group 1 Group 2
1 103.9 103.6 100.85 107.5
2 99.0 115.8 94.9 109.5
3 116.0 109.7 93.52 105.3
4 110.8 109.4 94.30 116.9
5 119.2 108.7 91.92 104.5
6 1156 105.3 97.75 105.9
7 110.6 110.5 94.02 107.2
8 113.9 111.3 94.64 115.7
9 114.7 104.2 90.76 107.2
10 116.2 107.9 92.89 103.3
11 111.2 116.8 93.32 105.7
12 112.4 117.6 95.28 107.1
13 114.6 114.3 95.29 102.5
14 116.2 108.9 92.86 103.4
15 108.2 110.1 93.43 106.2
16 114.1 108.5 93.84 104.5
17 117.9 112.6 94.22 105.1
18 110.3 104.9 97.32 106.7
19 114.8 105.8
20 111.9 107.1
21 109.9